UNH news live: negative momentum dominates, resistance set near $352.61 amid weak rebound odds

Traders Union
All News
Financial News
Unitedhealth slides 0.26% today

Highlights

UnitedHealth Group (UNH) closed at $326.66, trading well below its MA-20 ($354.84), MA-50 ($345.04), and MA-200 ($383.54), indicating persistent technical weakness.
Q3 revenues exceeded $113 billion with 12% year-over-year growth, but operating earnings fell 57% to $1.8 billion due to higher claims and aging membership.
Technicals show severe downside momentum—RSI at 32.37, Stoch RSI at 0.00, and CCI at –197.45—putting further declines at risk if UNH drops below $326.

Earnings decline and higher claims offset record revenues and guidance lift

UnitedHealth Group reported third-quarter revenues above $113 billion, with a 12% year-over-year growth driven by domestic membership gains, though operating earnings fell 57% to $1.8 billion due to increased claims costs and aging membership. The company also raised its 2025 net earnings and adjusted EPS guidance, sustained a steady $5.9 billion in quarterly cash flow, and maintained a debt-to-capital ratio at 44.1% despite the Amedisys acquisition. Quarterly dividends were reaffirmed at $2.21 per share, boosted by a 25-year streak of increases, while institutional investors broadly maintained or expanded positions. Ongoing investments in digital health and the potential impact of a federal government shutdown on insurance cost dynamics round out recent developments.

Momentum weakens as downside pressure breaks through technical support

Persistent downside momentum dominates technicals, with UNH maintaining a position well below key short-, medium-, and long-term moving averages. The Ichimoku Kijun line at $352.61 adds dynamic resistance, and there are no strong support levels nearby. Momentum remains negative as indicated by a declining ADX, neutral D1 MACD (with pronounced bearishness on intraday timeframes), and deeply oversold oscillator values: RSI at 32.37, Stoch RSI at 0.00, CCI at –197.45, and BBP at –16.37. The Awesome Oscillator's negative reading supports continued bearish sentiment.

Further downside risk builds as rebound chances stay limited

Over the coming week, UNH is likely to trade within a narrow corridor between $336.28 and $338.66, with a less than 20% probability of a short-term rebound. The baseline expectation is continued consolidation below key resistance near $352.61, and any bullish recovery would rely on a sustained breakout above this level. Downward momentum, negative weekly trends, and prevailing technical signals put further downside at greater risk, especially if the price slips under $326.

Anton Kharitonov, expert at Traders Union, notes that UnitedHealth Group remains under pronounced selling pressure, as bearish technical momentum aligns with disappointing operating earnings and rising claims costs. He sees little technical support below the current price, with all key moving averages trending above and momentum indicators deeply oversold. Although the company shows strength in cash flow and institutional holdings, the analyst points out that near-term risks—especially a slip below $326—continue to outweigh rebound scenarios. "Given persistent downside signals and lacking confirmation of a reversal, my tactical stance stays defensive unless UNH decisively reclaims resistance at $352.61."

Last time we reported that mixed momentum and range-bound action signaled ongoing indecision among buyers and sellers. Previously, analysts noted that oscillators indicated oversold conditions even as resistance capped any significant rebound attempts.

Source of Data: UNH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.